Press release
Myopia Pipeline 2024 | Sydnexis, Sunhawk Vision Biotech, Vyluma, Eyenovia, Cloudbreak Therapeutics, Stuart Therapeutics
Discover the latest drugs and treatment options in the Myopia Pipeline. Dive into DelveInsight's comprehensive report today! @ Myopia Pipeline Outlook [https://www.delveinsight.com/sample-request/myopia-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Myopia Pipeline Report
* July 2024:- Hoffmann-La Roche - This is a Phase III, multicenter, randomized, double-masked, active comparator-controlled study evaluating the efficacy and safety of faricimab in patients with myopic choroidal neovascularization (CNV). This non-inferiority study will compare 6.0 mg faricimab versus 0.5 mg ranibizumab administered at a pro-re-nata (PRN) dosing regimen after an initial active IVT treatment administration at randomization (Day 1).
* July 2024:- VIS Inc. - The goal of this clinical trial is to evaluate the safety and efficacy of using the VIS Opti-K System to enable monovision by providing temporary improvement in near vision through the treatment of the non-dominant eye of low myopic, emmetropic and low hyperopic presbyope subjects. The main questions it aims to answer are determining uncorrected near visual acuity at 40cm in the treated eye and subjective improvement as measured by the patient satisfaction questionnaire.
* DelveInsight's Myopia pipeline report depicts a robust space with 8+ active players working to develop 10+ pipeline therapies for Myopia treatment.
* The leading Myopia Companies such as Sydnexis, Sunhawk Vision Biotech, Vyluma, Eyenovia, Cloudbreak Therapeutics, Stuart Therapeutics , and others.
* Promising Myopia Therapies such as SYD-101 Dose 1, Alleance, NVK-002 Concentration 1, QLM3004 Concentration 1, Atropine Sulfate 01, and others.
Stay ahead with the most recent pipeline outlook for Myopia. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Myopia Treatment Drugs [https://www.delveinsight.com/sample-request/myopia-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Myopia Emerging Drugs Profile
* Atropine micro-formulation (MicroPine): Eyenovia
MicroPine is a proprietary microdose formulation of atropine used in our Optejet dispenser and product candidate for the prevention of progressive myopia (nearsightedness) in children. It is believed that Eyenovia's delivery technology is particularly well-suited for this application and patient population, potentially enabling children to easily self-administer atropine medication while minimizing dose-related side effects. Currently, the drug is in Phase III stage of its clinical trial for the treatment of Myopia.
* SYD-101: Sydnexis
SYD-101 is an investigational low-dose atropine sulfate ophthalmic solution, 0.01% and 0.03%, designed to achieve efficacy, stability, and reduce discomfort for improved treatment continuity, according to studies on the treatment of childhood myopia. While published reports have shown low concentrations of compounded atropine to be effective, these solutions are limited by short shelf life and remain only stable if markedly acidified, which can also cause excessive burning and stinging in children, according to several studies on atropine for myopia. Currently, the drug is in phase III stage of its clinical trial for the treatment of Myopia.
Explore groundbreaking therapies and clinical trials in the Myopia Pipeline. Access DelveInsight's detailed report now! @ New Myopia Drugs [https://www.delveinsight.com/sample-request/myopia-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Myopia pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration
* Intra-articular
* Intraocular
* Intrathecal
* Intravenous
* Ophthalmic
* Oral
* Parenteral
* Subcutaneous
* Topical
* Transdermal
Myopia Products have been categorized under various Molecule types such as
* Oligonucleotide
* Peptide
* Small molecule
Unveil the future of Myopia Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight's expert analysis @ Myopia Market Drivers and Barriers [https://www.delveinsight.com/sample-request/myopia-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Myopia Pipeline Report
* Coverage- Global
* Myopia Companies- Sydnexis, Sunhawk Vision Biotech, Vyluma, Eyenovia, Cloudbreak Therapeutics, Stuart Therapeutics, and others.
* Myopia Therapies- SYD-101 Dose 1, Alleance, NVK-002 Concentration 1, QLM3004 Concentration 1, Atropine Sulfate 01, and others.
* Myopia Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Myopia Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Get the latest on Myopia Therapies and clinical trials. Download DelveInsight's in-depth pipeline report today! @ Myopia Companies, Key Products and Unmet Needs [https://www.delveinsight.com/sample-request/myopia-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
* Introduction
* Executive Summary
* Myopia: Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Myopia - DelveInsight's Analytical Perspective
* Late Stage Products (Phase III)
* Atropine micro-formulation (MicroPine): Eyenovia
* Drug profiles in the detailed report.....
* Mid Stage Products (Phase II)
* Drug Name: Company Name
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I)
* Drug Name: Company Name
* Drug profiles in the detailed report.....
* Preclinical Stage Products
* Drug Name: Company Name
* Drug profiles in the detailed report.....
* Inactive Products
* Myopia - Collaborations Assessment- Licensing / Partnering / Funding
* Myopia - Unmet Needs
* Myopia - Market Drivers and Barriers
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=myopia-pipeline-2024-sydnexis-sunhawk-vision-biotech-vyluma-eyenovia-cloudbreak-therapeutics-stuart-therapeutics]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Myopia Pipeline 2024 | Sydnexis, Sunhawk Vision Biotech, Vyluma, Eyenovia, Cloudbreak Therapeutics, Stuart Therapeutics here
News-ID: 3611312 • Views: …
More Releases from ABNewswire
Caliente Brands Targets Niche Spice Market with Hickory-Smoked Beef Jerky Line F …
Caliente Brands, LLC capitalizes on growing consumer demand for authentically spicy snacks with a specialized beef jerky line that puts heat first. Using only 100% USDA Approved Beef and hickory smoking techniques, the veteran-owned company offers distinctive flavors including innovative Spicy Birria alongside traditional options, all designed to deliver the brand promise that smoky and spicy meet delicious.
Caliente Brands, LLC has strategically positioned itself to serve a niche but substantial…
Manaslu Circuit Trek Offers the Real Taste of Wilderness Adventure in the Himala …
Kathmandu, Nepal - Peace Nepal Treks announces expanded departures for the Manaslu Circuit Trek, a high Himalayan journey known for raw landscapes, cultural depth, and challenging terrain. This route delivers a true wilderness experience for trekkers seeking remote adventure beyond crowded trails.
The Manaslu Circuit Trek encircles Mount Manaslu at 8,163 meters, the eighth highest peak on Earth. The trail crosses Larke Pass at 5,106 meters and moves through steep gorges,…
Custom Cardboard Boxes: Complete Buyer Guide
Image: https://www.abnewswire.com/upload/2026/02/0f0fee39afaa0d25711f34ee831a6f6f.jpg
Packaging protects merchandise and shapes first impressions. It additionally impacts transport value, and consumers agree with it. In today's market, brands need packaging that is strong, flexible, and affordable. This is where custom cardboard packing boxes play a crucial role.
Custom cardboard boxes [https://www.thecustomboxes.com/cardboard-boxes/] are used by small groups and large brands alike. They paint retail shelves, online orders, and warehouse garages. They are easy to print, smooth to recycle,…
Mondressy Unveils Its 2026 Defining Colors: The Five Essential Shades of "Matria …
Top 5 color palettes for 2026 spotlight navy blue, champagne, black, dark green, and burgundy for the modern mother-of-the-occasion wardrobe.
Mondressy has officially introduced its 2026 defining colors, identifying five essential shades that embody what the brand calls "Matriarchal Authority and Elegance." The brand's 2026 color direction centers on navy blue, champagne, black, dark green, and burgundy, a five-color foundation designed for mother-of-the-bride dresses [https://mondressy.com/collections/mother-of-the-bride-dresses] to help mothers step into milestone…
More Releases for Myopia
Myopia Market Assessment & Forecast: Strategic Insights into Pediatric Myopia Ma …
Albany, United States - September 25, 2025 - DelveInsight, a leading provider of market intelligence and strategic consulting services in the healthcare sector, has released a comprehensive case study report on Myopia Market Assessment & Forecast, providing in-depth insights into the pediatric myopia landscape across Asia. This detailed study highlights prevalence trends, treatment paradigms, and market opportunities, equipping stakeholders with the actionable intelligence required to make informed decisions in the…
Myopia Control Lenses Market Forecast to Expand at 16.2% CAGR Amid Increasing Pe …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Myopia Control Lenses Market- (By Lens Type (Multifocal Lenses, Orthokeratology Lenses, Dual-Focus Lenses, Peripheral Defocus Lenses), By Age Group (Children, Adults), By Distribution Channel (Optometry Clinics, Optical Retail Stores, Online Retail)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Myopia Control Lenses Market is valued…
Myopia Control Lenses Market Size to Grow with Rising Prevalence of Childhood My …
The latest Myopia Control Lenses Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2025 and 2032. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The Industry compass guiding business through the complexities of the market, presenting not only the current landscape but also the latest innovations shaping its…
Myopia Control Devices Market - Seeing Beyond Blur: Revolutionary Myopia Devices …
Newark, New Castle, USA: The "Myopia Control Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Myopia Control Devices Market: https://www.growthplusreports.com/report/myopia-control-devices-market/7989
This latest report researches the industry structure,…
Myopia Control Devices Market - Unlocking the Future of Clear Sight: Myopia Cont …
Newark, New Castle, USA - new report, titled Myopia Control Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Myopia Control Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Myopia Control Devices market. The report offers an overview of…
The Myopia Market is expected to be driven by the factors such as the rising cas …
The Myopia market is expected to show positive growth, mainly attributed to the increased diagnosed prevalence and also, the launch of upcoming devices during the forecast period. Moreover, advances in disease mechanisms have yielded new diagnostic and treatment approaches, opening avenues to better treatment interventions.
The Myopia market report provides current treatment practices, emerging drugs, Myopia market share of the individual therapies, current and forecasted Myopia market Size from 2019 to…
